US Stock MarketDetailed Quotes

OBLN Obalon Therapeutics

Watchlist

0.000
0.0000.00%

Close Nov 6 09:30 ET

0Market Cap0.00P/E (TTM)

Obalon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

(Q3)Sep 30, 2019

(Q2)Jun 30, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

7.73%-4.44M

54.48%-10.41M

68.13%-1.56M

67.66%-1.29M

36.87%-2.75M

50.07%-4.81M

22.31%-22.87M

9.90%-4.88M

24.64%-3.99M

46.37%-4.36M

Net income from continuing operations

20.79%-4.17M

47.91%-12.33M

73.03%-1.33M

57.91%-1.56M

38.11%-4.19M

36.54%-5.26M

36.66%-23.68M

43.89%-4.91M

45.06%-3.71M

30.62%-6.77M

Operating gains losses

----

19.63%128K

--0

--33K

----

Depreciation and amortization

-26.22%166K

-5.70%843K

-11.64%205K

-3.64%212K

0.50%201K

-7.02%225K

53.87%894K

51.63%232K

44.74%220K

36.05%200K

Other non cash items

----

18.57%83K

--31K

----

89.19%70K

--0

336.36%48K

Change In working capital

-114.52%-532K

57.09%-1.4M

39.39%-534K

78.83%-253K

-123.83%-365K

90.88%-248K

-226.47%-3.26M

-141.42%-881K

-499.67%-1.2M

486.97%1.53M

-Change in receivables

--0

-51.28%285K

--0

-66.64%461K

81.65%-176K

-82.55%585K

-102.47%-47K

-23.72%209K

378.63%1.38M

-Change in inventory

--0

-4,475.00%-525K

-100.78%-1K

--0

23.55%-198K

-419.61%-326K

107.41%12K

-65.60%129K

135.40%40K

-1,136.00%-259K

-Change in payables and accrued expense

-107.82%-33K

93.92%-33K

-122.65%-41K

25.52%-397K

68.52%-17K

408.03%422K

-875.71%-543K

378.46%181K

-280.71%-533K

93.24%-54K

-Change in other current assets

103.82%108K

-538.93%-1.8M

65.21%-415K

392.31%456K

17.44%983K

-406.39%-2.83M

319.39%411K

-68.74%-1.19M

-200.00%-156K

153.64%837K

-Change in other current liabilities

-74.28%789K

325.89%1.84M

113.24%27K

64.56%-118K

-163.57%-1.14M

1,905.23%3.07M

-1,298.53%-815K

63.96%-204K

-60.10%-333K

-146.10%-431K

-Change in other working capital

-242.16%-1.4M

60.04%-1.16M

-141.11%-104K

54.03%-194K

-903.51%-458K

85.43%-408K

-243.92%-2.91M

-78.65%253K

-178.44%-422K

-78.57%57K

Cash from discontinued investing activities

Operating cash flow

7.73%-4.44M

54.48%-10.41M

68.13%-1.56M

67.66%-1.29M

36.87%-2.75M

50.07%-4.81M

22.31%-22.87M

9.90%-4.88M

24.64%-3.99M

46.37%-4.36M

Investing cash flow

Cash flow from continuing investing activities

-107.26%-171K

64.00%-54K

21,000.00%209K

-112.88%-326K

-87.93%2.36M

-102.89%-150K

99.67%-24K

99.92%-1K

Net PPE purchase and sale

----

11.86%-171K

64.00%-54K

--0

21,000.00%209K

-1,615.79%-326K

84.87%-194K

63.86%-150K

88.57%-24K

99.67%-1K

Net investment purchase and sale

----

--0

----

-87.74%2.55M

--0

Cash from discontinued investing activities

Investing cash flow

--0

-107.26%-171K

64.00%-54K

--0

21,000.00%209K

-112.88%-326K

-87.93%2.36M

-102.89%-150K

99.67%-24K

99.92%-1K

Financing cash flow

Cash flow from continuing financing activities

9.51M

-96.79%430K

106.31%430K

33.86%13.38M

-119.26%-296K

-0.70%9.88M

-4,612.58%-6.81M

Net issuance payments of debt

----

104.30%430K

--0

----

---10M

--0

---5M

---15M

Net common stock issuance

----

--0

----

137.98%23.38M

-97.33%-296K

49.20%14.88M

--8.19M

Proceeds from stock option exercised by employees

--9.51M

--0

-99.50%1K

--0

Cash from discontinued financing activities

Financing cash flow

--9.51M

-96.79%430K

--0

106.31%430K

--0

33.86%13.38M

-119.26%-296K

-0.70%9.88M

-4,612.58%-6.81M

Net cash flow

Beginning cash position

-72.22%3.91M

-33.66%14.06M

-71.55%5.51M

-49.65%6.8M

-63.88%8.92M

-33.66%14.06M

0.37%21.19M

-10.08%19.38M

-44.19%13.51M

-26.27%24.68M

Current changes in cash

198.58%5.07M

-42.32%-10.15M

69.78%-1.61M

-121.99%-1.29M

81.10%-2.11M

-246.98%-5.14M

-9,127.85%-7.13M

-1,358.90%-5.33M

320.56%5.87M

-20.56%-11.17M

End cash Position

0.64%8.97M

-72.22%3.91M

-71.55%5.51M

-49.65%6.8M

-63.88%8.92M

-33.66%14.06M

-10.08%19.38M

-44.19%13.51M

Free cash flow

13.58%-4.44M

54.12%-10.58M

68.01%-1.61M

67.85%-1.29M

41.68%-2.54M

46.80%-5.14M

24.92%-23.06M

13.74%-5.03M

27.08%-4.01M

48.26%-4.36M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019	(Q3)Sep 30, 2019	(Q2)Jun 30, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	7.73%-4.44M	54.48%-10.41M	68.13%-1.56M	67.66%-1.29M	36.87%-2.75M	50.07%-4.81M	22.31%-22.87M	9.90%-4.88M	24.64%-3.99M	46.37%-4.36M
Net income from continuing operations	20.79%-4.17M	47.91%-12.33M	73.03%-1.33M	57.91%-1.56M	38.11%-4.19M	36.54%-5.26M	36.66%-23.68M	43.89%-4.91M	45.06%-3.71M	30.62%-6.77M
Operating gains losses	----	----	----	----	----	----	19.63%128K	--0	--33K	----
Depreciation and amortization	-26.22%166K	-5.70%843K	-11.64%205K	-3.64%212K	0.50%201K	-7.02%225K	53.87%894K	51.63%232K	44.74%220K	36.05%200K
Other non cash items	----	18.57%83K	--31K	----	----	----	89.19%70K	--0	--0	336.36%48K
Change In working capital	-114.52%-532K	57.09%-1.4M	39.39%-534K	78.83%-253K	-123.83%-365K	90.88%-248K	-226.47%-3.26M	-141.42%-881K	-499.67%-1.2M	486.97%1.53M
-Change in receivables	--0	-51.28%285K	--0	--0	-66.64%461K	81.65%-176K	-82.55%585K	-102.47%-47K	-23.72%209K	378.63%1.38M
-Change in inventory	--0	-4,475.00%-525K	-100.78%-1K	--0	23.55%-198K	-419.61%-326K	107.41%12K	-65.60%129K	135.40%40K	-1,136.00%-259K
-Change in payables and accrued expense	-107.82%-33K	93.92%-33K	-122.65%-41K	25.52%-397K	68.52%-17K	408.03%422K	-875.71%-543K	378.46%181K	-280.71%-533K	93.24%-54K
-Change in other current assets	103.82%108K	-538.93%-1.8M	65.21%-415K	392.31%456K	17.44%983K	-406.39%-2.83M	319.39%411K	-68.74%-1.19M	-200.00%-156K	153.64%837K
-Change in other current liabilities	-74.28%789K	325.89%1.84M	113.24%27K	64.56%-118K	-163.57%-1.14M	1,905.23%3.07M	-1,298.53%-815K	63.96%-204K	-60.10%-333K	-146.10%-431K
-Change in other working capital	-242.16%-1.4M	60.04%-1.16M	-141.11%-104K	54.03%-194K	-903.51%-458K	85.43%-408K	-243.92%-2.91M	-78.65%253K	-178.44%-422K	-78.57%57K
Cash from discontinued investing activities
Operating cash flow	7.73%-4.44M	54.48%-10.41M	68.13%-1.56M	67.66%-1.29M	36.87%-2.75M	50.07%-4.81M	22.31%-22.87M	9.90%-4.88M	24.64%-3.99M	46.37%-4.36M
Investing cash flow
Cash flow from continuing investing activities		-107.26%-171K	64.00%-54K	0	21,000.00%209K	-112.88%-326K	-87.93%2.36M	-102.89%-150K	99.67%-24K	99.92%-1K
Net PPE purchase and sale	----	11.86%-171K	64.00%-54K	--0	21,000.00%209K	-1,615.79%-326K	84.87%-194K	63.86%-150K	88.57%-24K	99.67%-1K
Net investment purchase and sale	----	--0	--0	--0	----	----	-87.74%2.55M	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	--0	-107.26%-171K	64.00%-54K	--0	21,000.00%209K	-112.88%-326K	-87.93%2.36M	-102.89%-150K	99.67%-24K	99.92%-1K
Financing cash flow
Cash flow from continuing financing activities	9.51M	-96.79%430K	0	0	106.31%430K	0	33.86%13.38M	-119.26%-296K	-0.70%9.88M	-4,612.58%-6.81M
Net issuance payments of debt	----	104.30%430K	--0	--0	----	----	---10M	--0	---5M	---15M
Net common stock issuance	----	--0	--0	--0	----	----	137.98%23.38M	-97.33%-296K	49.20%14.88M	--8.19M
Proceeds from stock option exercised by employees	--9.51M	--0	--0	--0	--0	--0	-99.50%1K	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	--9.51M	-96.79%430K	--0	--0	106.31%430K	--0	33.86%13.38M	-119.26%-296K	-0.70%9.88M	-4,612.58%-6.81M
Net cash flow
Beginning cash position	-72.22%3.91M	-33.66%14.06M	-71.55%5.51M	-49.65%6.8M	-63.88%8.92M	-33.66%14.06M	0.37%21.19M	-10.08%19.38M	-44.19%13.51M	-26.27%24.68M
Current changes in cash	198.58%5.07M	-42.32%-10.15M	69.78%-1.61M	-121.99%-1.29M	81.10%-2.11M	-246.98%-5.14M	-9,127.85%-7.13M	-1,358.90%-5.33M	320.56%5.87M	-20.56%-11.17M
End cash Position	0.64%8.97M	-72.22%3.91M	-72.22%3.91M	-71.55%5.51M	-49.65%6.8M	-63.88%8.92M	-33.66%14.06M	-33.66%14.06M	-10.08%19.38M	-44.19%13.51M
Free cash flow	13.58%-4.44M	54.12%-10.58M	68.01%-1.61M	67.85%-1.29M	41.68%-2.54M	46.80%-5.14M	24.92%-23.06M	13.74%-5.03M	27.08%-4.01M	48.26%-4.36M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data